The Taliban had announced they have contracted an Australian company “Cpharm” to grow and manufacture cannabis products—something the company later denied, saying they have no idea what the Taliban are talking about.
The Afghan Interior Ministry said the company, Cpharm, agreed to make an investment worth more than $400 million, which also provides jobs to hundreds of people.
“The Deputy Minister for Counter Narcotics, Ministry of Interior Affairs met with a representative of Cpharm Company. Cpharm will invest $450 million in setting up a hashish-processing company in Afghanistan,” the ministry said in a tweet.
“Medicines and creams would be manufactured by the hashish-processing factory. The project will be officially launched soon and hundreds of people will get job opportunities on the project,” it added.
But the Australian company later said it has no idea what the Taliban is talking about.
“We have become aware overnight of numerous media articles stating that Cpharm in Australia has been involved in a deal with the Taliban to be involved in the supply of cannabis in a cream,” the company said in a press release.
“We DO NOT manufacture or supply anything. We provide a medical advice service to the pharmaceutical industry within Australia. We have no products on the ARTG. We have no connection with cannabis or the Taliban. We have no idea where the Taliban media release has come from and want to assure everyone that it should not be connected to Cpharm Pty Ltd Australia.”
Moreover, a Taliban spokesman for the Interior Ministry, Qari Saeed Khosty in a tweet said only Cpharm Company will use cannabis produced in Afghanistan to make spices and a kind of cream.
© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.